Showing 880 – 890 of 1159 results
-
PowerSchool Holdings Inc Initiation
William Blair initiated research coverage of PowerSchool Holdings, Inc. (PWSC $25.57), an end-to-end, predominantly SaaS platform for the K-12 education industry.
-
Coursera Inc Initiation
William Blair initiated research coverage of Coursera, Inc. (COUR $44.16), which provides a learning platform with high-quality content from university/corporate partners.
-
PFAS Solutions The Potential Impact of Loper Bright
In this episode of William Blair Thinking Presents, Tim Mulrooney, group head of global services, follows up on his last episode about the PFAS market to detail how the recent Supreme Court ruling known as Loper Bright could have far-reaching implications for all types of regulations, including environmental ones like PFAS.
-
On the Ground and in the Cloud Observability and AIOps
William Blair tech analyst Jake Roberge joins the show to discuss the observability and AIOps software markets, including the increasingly important role these platforms are playing for businesses of all sizes, why they are gaining momentum over legacy monitoring tools, and some of the key trends he’s seeing in the market.
-
Cell Therapy and Autoimmune Disorders
Equity research analysts Sami Corwin and Matt Phipps provide an overview of the known biological underpinnings of autoimmunity and the rationale for using chimeric antigen receptor T cells (CAR-Ts) to potentially treat millions who suffer from autoimmune diseases.
-
CareDx Inc Initiation
William Blair initiated research coverage of CareDx, Inc. (CDNA $12.51), which provides diagnostics and digital solutions for transplant patients and providers.
-
Nkarta Inc Initiation
William Blair initiated research coverage of Nkarta, Inc. (NKTX $14.27), a clinical-stage company focused on the development and commercialization of genetically engineered allogeneic chimeric antigen receptor (CAR) natural killer (NK) cell therapies for the treatment of cancer.
-
argenx SE Initiation
William Blair initiated research coverage of argenx SE ($393.26), a global immunology company focused on antibody-based therapies to treat rare autoimmune diseases.
-
Five9 Inc Initiation
William Blair initiated research coverage of Five9, Inc. (FIVN $120.60), which provides cloud contact center technology and solutions to businesses of all sizes.
-
BigBearai Holdings Inc Initiation
William Blair initiated research coverage of BigBear.ai Holdings, Inc. (BBAI $5.20), a provider of data analytics and IT solutions for the U.S. government.